BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sollelis E, Quinard RM, Bouguen G, Goutte M, Goutorbe F, Bouvier D, Pereira B, Bommelaer G, Buisson A. Combined evaluation of biomarkers as predictor of maintained remission in Crohn’s disease. World J Gastroenterol 2019; 25(19): 2354-2364 [PMID: 31148906 DOI: 10.3748/wjg.v25.i19.2354]
URL: https://www.wjgnet.com/1007-9327/full/v25/i19/2354.htm
Number Citing Articles
1
Steve Halligan, Darren Boone, Lucinda Archer, Tariq Ahmad, Stuart Bloom, Manuel Rodriguez-Justo, Stuart A Taylor, Sue Mallett. Prognostic biomarkers to identify patients likely to develop severe Crohn’s disease: a systematic reviewHealth Technology Assessment 2021; 25(45): 1 doi: 10.3310/hta25450
2
Dan Turner, Amanda Ricciuto, Ayanna Lewis, Ferdinando D’Amico, Jasbir Dhaliwal, Anne M. Griffiths, Dominik Bettenworth, William J. Sandborn, Bruce E. Sands, Walter Reinisch, Jürgen Schölmerich, Willem Bemelman, Silvio Danese, Jean Yves Mary, David Rubin, Jean-Frederic Colombel, Laurent Peyrin-Biroulet, Iris Dotan, Maria T. Abreu, Axel Dignass. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBDGastroenterology 2021; 160(5): 1570 doi: 10.1053/j.gastro.2020.12.031
3
Lorant Gonczi, Talat Bessissow, Peter Laszlo Lakatos. Disease monitoring strategies in inflammatory bowel diseases: What do we mean by “tight control”?World Journal of Gastroenterology 2019; 25(41): 6172-6189 doi: 10.3748/wjg.v25.i41.6172